Cowen analyst Phil Nadeau initiates coverage on Cabaletta Bio Inc. (NASDAQ: CABA) with a Outperform rating.The analyst comments "Cabaletta is ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE